Gout: all 236 studies

Page 2 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.

• Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)CompletedNCT00856206Phase 3Results posted
• Study Utilizing Rilonacept in Gout ExacerbationsCompletedNCT00855920Phase 3Results posted
• PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1CompletedNCT00829829Phase 3Results posted
• A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)CompletedNCT00819585Phase 2Results posted
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout PatientsCompletedNCT00798369Phase 2Results posted
• Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout PatientsCompletedNCT00675103Phase 3Results posted
• Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout FlaresCompletedNCT00610363Phase 2Results posted
• MPC-004 for the Treatment of an Acute Gout FlareCompletedNCT00506883Phase 3Results posted
• Efficacy and Safety of Oral Febuxostat in Participants With GoutCompletedNCT00430248Phase 3Results posted
• Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic GoutCompletedNCT00325195Phase 3Results posted
• Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010CompletedNCT00175019Phase 3Results posted
• Validation Study of Physical Measurement of TophiCompletedNCT00175006Results posted
• Dose-Response, Safety and Efficacy of Febuxostat in Subjects With GoutCompletedNCT00174967Phase 2Results posted
• Long-Term Safety of Febuxostat in Subjects With Gout.CompletedNCT00174941Phase 2Results posted
• Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.CompletedNCT00174915Phase 3Results posted
• Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory GoutCompletedNCT00111657Phase 2Results posted
• Febuxostat Versus Allopurinol Control Trial in Subjects With GoutCompletedNCT00102440Phase 3Results posted
• Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With GoutCompletedNCT07752810Phase 1/2
• Long-Term Risk of Gout in Living Kidney DonorsActive, not recruitingNCT07546643
• Tigulixostat (IBI128) vs Febuxostat in GoutActive, not recruitingNCT07414394Phase 3
• Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy SubjectsActive, not recruitingNCT07366749Not applicable
• Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsActive, not recruitingNCT07116746Phase 2
• Using Gout Buddy to Enhance Gout ManagementActive, not recruitingNCT07004231Not applicable
• Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic PatientsCompletedNCT06995339Phase 2
• Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)CompletedNCT06846515Phase 3
• Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and HyperuricemiaActive, not recruitingNCT06603142Phase 2/3
• A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout SubjectsCompletedNCT06501534Phase 2
• Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)CompletedNCT06439602Phase 3
• Extension Study of ABP-671 in Participants With GoutTerminatedNCT06276556Phase 2/3
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy VolunteersCompletedNCT06258213Phase 1
• Prevalence of Musculoskeletal Complaints in Nursing Home ResidentsCompletedNCT06235710
• The Remote Monitoring of Gout Feasibility StudyCompletedNCT06211322Not applicable
• UR+AIMS Gout Wearable Skin Uric Acid Monitor StudyCompletedNCT06187519Not applicable
• Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous GoutCompletedNCT06186219Phase 1
• A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)CompletedNCT05936281Phase 2
• Safety and Efficacy of Genakumab for Injection in Patients With Gout FlareCompletedNCT05936268Phase 2
• Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With GoutCompletedNCT05818085Phase 2/3
• A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout PatientsCompletedNCT05815901Phase 3
• A Exploratory Trial of WTX221 in Refractory Gout PatientsStatus unknownNCT05800041Early Phase 1
• NLRP3 Inflammasome Activation Among Patients During Acute Gout FlaresStatus unknownNCT05744297
• Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.Active, not recruitingNCT05690204Phase 2
• Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With GoutCompletedNCT05665699Phase 2
• Genetic of Chronic Kidney Disease and Gout in New CaledoniaCompletedNCT05607797Not applicable
• A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutStatus unknownNCT05588908Phase 1/2
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsCompletedNCT05586971Phase 3
• Tigulixostat, Phase 3 Study, Placebo Controlled in Gout PatientsCompletedNCT05586958Phase 3
• Distribution of Immune Cells and Their Subtypes in Peripheral Blood of GoutActive, not recruitingNCT05522504
• Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and HyperuricemiaStatus unknownNCT05513976Phase 2
• Tight Control of Gouty Arthritis Compared to Usual CareActive, not recruitingNCT05507723Not applicable
• An Innovative Chinese Herbal Formula for the Treatment of GoutCompletedNCT05499312Phase 2
• Effect of Aquatic Exercise and Traditional Physical Therapy on Gout in Hypertensive Menopausal Women With HyperuricemiaStatus unknownNCT05454423Not applicable
• Imagery as Biomarker of GoutActive, not recruitingNCT05434858Not applicable
• A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in AdultsStatus unknownNCT05347498Phase 1
• Clinical Study of Genakumab for Injection in Patients With Acute GoutCompletedNCT05328531Phase 1/2
• To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With GoutStatus unknownNCT05324423Phase 1
• A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With GoutTerminatedNCT05256810Phase 1/2
• Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous GoutCompletedNCT05253833Phase 2
• A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple DosingCompletedNCT05127772Phase 1
• Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout PatientsCompletedNCT05119686Phase 2
• Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With GoutStatus unknownNCT05065606
• Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout PatientsStatus unknownNCT05006001
• Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney DiseaseTerminatedNCT04987294Phase 2
• A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With GoutCompletedNCT04956432Phase 3
• Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of GoutStatus unknownNCT04953533
• Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)CompletedNCT04938024Not applicable
• Tahiti-families: Polynesian Families of Gout PatientsCompletedNCT04900090Not applicable
• Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal TransplantationSuspendedNCT04844814Phase 2
• Epidemiology of Gout in French PolynesiaCompletedNCT04812886Not applicable
• Treatment of Refractory Gout With ACTH or MethylprednisoloneStatus unknownNCT04808856Not applicable
• Study of of URC102 to Assess the Efficacy and Safety in Gout PatientsCompletedNCT04804111Phase 2
• Treat-to-target by Email During Urate-lowering Therapy in GoutActive, not recruitingNCT04733079Not applicable
• Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in GoutTerminatedNCT04697602Not applicable
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or HyperuricemiaCompletedNCT04638543Phase 2
• Knowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in NepalCompletedNCT04519021
• ACTH vs Betamethasone in Hospitalized Patients With Acute GoutStatus unknownNCT04306653Not applicable
• A Pilot Study to Explore the Role of Gut Flora in GoutWithdrawnNCT04224662
• Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout PatientsCompletedNCT04155918Phase 2
• Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS)CompletedNCT04130204Phase 2
• Assessing the Role of the NLRP3 Inflammasome in Intercritical GoutActive, not recruitingNCT04125459
• Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat TherapyStatus unknownNCT04069325Not applicable
• A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With GoutCompletedNCT04052932Phase 3
• Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout PatientsCompletedNCT04040816Phase 2
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
• Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout FlareTerminatedNCT03933007Phase 4
• Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout PatientsCompletedNCT03857165Phase 1
• PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
• Weight Loss for Obese Individuals With GoutCompletedNCT03664167Not applicable
• Pharmacokinetics and Pharmacodynamics of AnthocyaninsCompletedNCT03650140Not applicable
• The Effect of Tart Cherry Juice on Risk of Gout AttacksTerminatedNCT03621215Not applicable
• The Percentage of Cases of Acute Treatment With Allopurinol in Gout PatientsStatus unknownNCT03601260Not applicable
• Vegetarian Diet and Chronic Degenerative DiseasesCompletedNCT03470584
• Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)CompletedNCT03375632Phase 1
• Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03372200Phase 3
• A Nurse Led Patient Management Programme to Improve Outcomes in GoutCompletedNCT03345186Not applicable
• The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)Status unknownNCT03336203Phase 4
• The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or GoutStatus unknownNCT03306758Not applicable
• Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate DepositCompletedNCT03162341Not applicable
• The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With GoutCompletedNCT03131583Phase 1
• Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03100318Phase 3
• Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03006445Phase 3

← Gout overview